Smruthi Organics Ltd
BSE:540686
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Smruthi Organics Ltd
Common Stock
Smruthi Organics Ltd
Common Stock Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Common Stock | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Smruthi Organics Ltd
BSE:540686
|
Common Stock
₹114.5m
|
CAGR 3-Years
0%
|
CAGR 5-Years
25%
|
CAGR 10-Years
12%
|
|
|
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
|
Common Stock
₹835m
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
|
|
Cipla Ltd
NSE:CIPLA
|
Common Stock
₹1.6B
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
0%
|
|
|
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
|
Common Stock
₹2.4B
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
0%
|
|
|
Lupin Ltd
NSE:LUPIN
|
Common Stock
₹913.6m
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
0%
|
|
|
T
|
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
|
Common Stock
₹1.7B
|
CAGR 3-Years
0%
|
CAGR 5-Years
15%
|
CAGR 10-Years
7%
|
|
Smruthi Organics Ltd
Glance View
Smruthi Organics Ltd. engages in the manufacture and sale of bulk drugs and drug intermediates. The company is headquartered in Solapur, Maharashtra. The company went IPO on 2017-08-29. The Company’s operating segments include Formulation. The firm's products include AMLODIPINE BESILATE, AMISULPRIDE, CARBIDOPA, CIPROFLOXACIN, DILOXANIDE FUROATE, FENOFIBRATE, METFORMIN HYDROCHLORIDE, NORFLOXACIN, PEFLOXACIN, TELMISARTAN, AMLODIPINE BASE and PHTHALOYL AMLODIPINE. The firm has 2 manufacturing facilities in Solapur, Maharashtra. with a combined reactor capacity of over 320 kiloliters. The firm manufactures API from kilo to metric ton scale. The firm serves pharmaceutical companies in India and across the globe. The firm caters to both domestic and international markets.
See Also
What is Smruthi Organics Ltd's Common Stock?
Common Stock
114.5m
INR
Based on the financial report for Dec 31, 2025, Smruthi Organics Ltd's Common Stock amounts to 114.5m INR.
What is Smruthi Organics Ltd's Common Stock growth rate?
Common Stock CAGR 10Y
12%
Over the last year, the Common Stock growth was 0%.
